Labcorp Holdings Inc. Files 8-K on Financials

Ticker: LH · Form: 8-K · Filed: 2025-02-06T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Labcorp dropped its 8-K filing today, check the financials.

AI Summary

On February 6, 2025, LABCORP HOLDINGS INC. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 358 South Main Street, Burlington, North Carolina.

Why It Matters

This filing provides investors with crucial updates on Labcorp's financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of LABCORP HOLDINGS INC., and it includes Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on February 6, 2025.

What is the exact name of the registrant?

The exact name of the registrant is LABCORP HOLDINGS INC.

Where are LABCORP HOLDINGS INC.'s principal executive offices located?

LABCORP HOLDINGS INC.'s principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

What is the company's IRS Employer Identification Number?

The company's IRS Employer Identification Number is 99-2588107.

From the Filing

0000920148-25-000021.txt : 20250206 0000920148-25-000021.hdr.sgml : 20250206 20250206065401 ACCESSION NUMBER: 0000920148-25-000021 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250206 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250206 DATE AS OF CHANGE: 20250206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 25595394 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20250206.htm 8-K lh-20250206 0000920148 false 0000920148 2025-02-06 2025-02-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 6, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated February 6, 2025 issued by Labcorp titled “ Labcorp Announces 2024 Fourth Quarter and Full Year Results ” Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: February 6, 2025 By: /s/ SANDRA VAN DER VAART     Sandra van der Vaart     Executive Vice President, Chief L

View on Read The Filing